Laraway Financial Advisors’s Novo Nordisk NVO Stock Holding History

Laraway Financial Advisors’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$280K	Sell	7,606 -400	-5%	-$19K	0.2%	113
2025 Q4	$407K	Hold	8,006	–	–	0.27%	81
2025 Q3	$444K	Buy	8,006 +600	+8%	+$35.1K	0.3%	74
2025 Q2	$511K	Hold	7,406	–	–	0.39%	65
2025 Q1	$514K	Hold	7,406	–	–	0.41%	62
2024 Q4	$637K	Hold	7,406	–	–	0.49%	54
2024 Q3	$882K	Hold	7,406	–	–	0.7%	41
2024 Q2	$1.06M	Hold	7,406	–	–	0.9%	33
2024 Q1	$951K	Buy	7,406 +50	+0.7%	+$5.95K	0.84%	34
2023 Q4	$761K	Sell	7,356 -300	-4%	-$29.7K	0.72%	37
2023 Q3	$696K	Sell	7,656 -400	-5%	-$35.2K	0.73%	43
2023 Q2	$652K	Sell	8,056 -600	-7%	-$49K	0.64%	48
2023 Q1	$689K	Buy	+8,656	New	+$614K	0.7%	45

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Laraway Financial Advisors's NVO Position: Q1 2026 in Review

Laraway Financial Advisors reduced its Novo Nordisk (NVO) stake by 5% in Q1 2026, selling an estimated $19K and leaving 7,606 shares worth $280K. The position accounts for 0.2% of the portfolio, ranked #113.

Laraway Financial Advisors first reported a position in NVO in Q1 2023 and has held it in 13 quarters since. The position peaked at $1.06M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Laraway Financial Advisors held 7,606 shares of Novo Nordisk worth $280K as of Q1 2026.
Laraway Financial Advisors sold 400 Novo Nordisk shares in Q1 2026, an estimated $19K.
Novo Nordisk made up 0.2% of Laraway Financial Advisors's portfolio in Q1 2026, its #113 holding.
Laraway Financial Advisors first reported a position in Novo Nordisk in Q1 2023 and has held it in 13 quarters since.
Laraway Financial Advisors's Novo Nordisk position peaked at $1.06M in Q2 2024.
1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Laraway Financial Advisors's 13F filing for Q1 2026, filed 14 May 2026.